Results 11 to 20 of about 3,279 (166)

New approaches to the assessment of rheumatoid arthritis activity: Simplified Disease Activity Index (SDAI) TOC \o "1-5" \h \z in early arthritis

Научно-практическая ревматология, 2005
Objective. To assess significance of Simplified Disease Activity Index (SDAI) in early arthritis. Material and methods . 76 pts with suspicion of rheumatoid arthritis (RA), duration of the disease less than 6 months (3,6±1,7 months), meanage48,5±14years ...
N A ChemeriS, D E Karateev, E L Nassonov
doaj   +2 more sources

A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens [PDF]

Reumatismo, 2011
Objective: To compare the SDAI values to DAS28 scores in RA patients undergoing different DMARD regimens. Methods: The SDAI is an unweighted numerical sum of five outcome parameters: tender and swollen joint count (based on 28-joint assessment), patient ...
Gabriele Valentini, Sergio Migliaresi, Giovanni La Montagna, Gabriella Molinaro, Giovanna Cuomo   +4 more
doaj   +2 more sources

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis [PDF]

Научно-практическая ревматология, 2012
Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) from the DAS 28, SDAI, and CDAI indices and to estimate remission rates from the European League Against Rheumatism (EULAR) criteria, and the new remission criteria proposed by the EULAR
Anastasia Sergeyevna Avdeyeva, E Yu Panasyuk, E N Aleksandrova, E L Nasonov   +3 more
doaj   +2 more sources

Remission versus low disease activity as treatment targets in rheumatoid arthritis: how to strike the right balance between too strict and too lenient targets? A meta-epidemiological study of individual patient data [PDF]

RMD Open
Objectives To evaluate the impact of using Simplified Disease Activity Index (SDAI)-LDA (low disease activity) versus different definitions of remission as a treatment target in established rheumatoid arthritis.Methods A meta-epidemiological study of ...
Désirée van der Heijde, Laure Gossec, Pedro M Machado, Johannes W G Jacobs, Paco M J Welsing, José António Pereira Da Silva, Ricardo J O Ferreira, Cátia Duarte   +7 more
doaj   +5 more sources

Effect of Achieving Sustained SDAI Remission on Erosion Healing in Early Rheumatoid Arthritis - A One-year Prospective HR-pQCT Study

Journal of Clinical Rheumatology and Immunology
Background Rheumatoid arthritis (RA) is a chronic inflammatory disease with progressive joint destruction. High-resolution peripheral quantitative CT (HR-pQCT) is a novel technique for detailed bone microstructure analysis allowing volumetric assessment ...
Qihan Wu, Ho So, Tsz-Ho Cheng, Yingzhao Jin, Sze-Lok Lau, Lai-shan Tam   +5 more
doaj   +2 more sources

Validación de un instrumento de ansiedad dental EQ-SDAI [PDF]

, 2019
Objective: The aim of this study was to validate an instrument of mass use to evaluate dental anxiety, by means of the dichotomization of a continuous variable of the Dental Anxiety Inventory short version instrument (SDAI) to a binary variable of ...
Maribel Llapa, Jaramillo, Zoila, Zoila Jaramillo, Paúl Coronel, Castillo, Dayana, María del Carmen Pariona, Villavicencio, Ebingen, Pariona, María del Carmen, Ebingen Villavicencio, Dayana Castillo, Coronel, Paúl, Llapa, Maribel   +11 more
core   +1 more source

Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice

Научно-практическая ревматология, 2019
Objective: to evaluate the clinical efficacy of the rituximab biosimilar Acellbia® at a dose of 600 mg intravenously at a 2-week interval in patients with active rheumatoid arthritis (RA) 12 and 24 weeks after initiation of treatment.Subjects and methods.
D. A. Kusevich, A. S. Avdeeva, V. V. Rybakova, N. V. Chichasova, E. L. Nasonov   +4 more
doaj   +1 more source

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis

Научно-практическая ревматология, 2012
Objective: to evaluate the impact of tocilizumab (TCZ) therapy on the level of acute-phase indicators, autoantibodies, and immunoglobulins (Ig) G, M, and A after 2, 4, 8, 12, and 24 weeks as compared to the clinical efficacy of TCZ using DAS 28, SDAI ...
Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, A A Novikov, M V Cherkasova, E L Nasonov   +5 more
doaj   +1 more source

Correlation between neutrophil-to-lymphocyte ratio and disease activity score using SDAI in established rheumatoid arthritis patients [PDF]

Romanian Journal of Rheumatology
Rheumatoid arthritis (RA) is a multisystem inflammatory disorder predominantly affecting joint structures leading to joint erosions, destruction of cartilage and frank deformities if not treated.
Tabe Rasool, Afshan Siddiqui, Salma Salman, Tahira Parveen, Faiza Ghuman, Iqra Haseeb   +5 more
doaj   +1 more source

The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study

Arthritis Research & Therapy, 2023
Background AVERT-2 (a phase IIIb, two-stage study) evaluated abatacept + methotrexate versus methotrexate alone, in methotrexate-naive, anti-citrullinated protein antibody-positive patients with early (≤ 6 months), active RA.
Paul Emery, Yoshiya Tanaka, Vivian P. Bykerk, Clifton O. Bingham, Thomas W. J. Huizinga, Gustavo Citera, Kuan-Hsiang Gary Huang, Chun Wu, Sean E. Connolly, Yedid Elbez, Robert Wong, Karissa Lozenski, Roy Fleischmann   +12 more
doaj   +1 more source